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Proteasome storage granuliProteasomes are highly conservedmultisubunit protease complexes and occur in the cyto- and nucleoplasmof eu-
karyotic cells. In dividing cells proteasomes exist as holoenzymes and primarily localize in the nucleus. During qui-
escence they dissociate into proteolytic core and regulatory complexes and are sequestered into motile cytosolic
clusters. Proteasome clusters rapidly clear upon the exit from quiescence, where proteasome core and regulatory
complexes reassemble and localize to the nucleus again. The mechanisms underlying proteasome transport and
assembly are not yet understood. Here, I summarize our present knowledge about nuclear transport and assembly
of proteasomes in yeast and project our studies in this eukaryotic model organism to the mammalian cell system.
This article is part of a Special Issue entitled: Ubiquitin–Proteasome System. Guest Editors: Thomas Sommer and
Dieter H. Wolf.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Almost thirty years ago, Varshavsky and co-workers discovered that
ubiquitin-dependent protein turnover is instrumental in the regulation
of cell cycle progression and gene expression [1]. A few years later, yeast
genetics by Dieter Wolf and his co-workers revealed that the
proteasome, a highly conserved multi-subunit protease, is the key en-
zyme for the degradation of proteins that are covalently linked with
poly-ubiquitin chains [2]. In this proteolytic system, ubiquitin serves
as degradation signal and the proteasome as the degrading enzyme. It
accounts for 80–90% of protein breakdown as estimated in cultured
mammalian cells. Its substrates comprise a large variety of short-lived
proteins that are conjugated to a poly-ubiquitin chain [3].
Proteins associated with nuclear functions, such as cyclins, cyclin-
dependent kinase inhibitors, and transcription factors (NF-κB,
IκB and p53), were among the ﬁrst physiological proteasomal
substrates to be identiﬁed [4,5]. Subsequently, cytoplasmic proteins
whose turnover was also dependent on the proteasome were
identiﬁed. Among these cytosolic proteins are newly synthesized
proteins that do not reach their intended conformation or location [6].
Decreased proteasome activity associated with aging may account
for the burden of aggregation-prone, age-dependent protein sub-
strates, a shared hallmark of neurodegenerative diseases [7].
However, it is still unclear whether proteasome dysfunction is a
cause or a consequence of these neurodegenerative diseases [8].tin–Proteasome System. Guest
rights reserved.In this review I will focus on our present knowledge about the
transport of proteasomes between the nucleo- and cytoplasm, a
process tightly linked with the assembly and disassembly of these
multi-subunit protease complexes.
2. The diversity of proteasome complexes
Throughout the eukaryotic kingdom proteasome complexes exist in
different conﬁgurations. All complexes have a catalytic core particle
(CP), but they differ in the number of associated regulatory particles
(RP) and accessory proteins. Named on the basis of their sedimentation
coefﬁcients, the 26S and 30S proteasomes contain one CP (20S) associ-
atedwith oneRP (19S) or two RP complexes, respectively. In addition to
the standard proteasome that degrades all kinds of short-lived proteins,
cytokine-inducible isoforms of the proteasome serve immune-speciﬁc
tasks in mammalian cells [9].
More than thirty different subunits are present in the mature
RP-CP assemblies. The CP contains seven distinct α and seven distinct
β subunits. These subunits are arranged into seven-membered rings
that are stacked to give a barrel-shaped particle with α7β7β7α7 con-
ﬁguration. The active site residues reside in the CP cavity formed by
both β rings.
The α rings are responsible for gating the central channels on both
sides of the CP barrel. Normally, the α ring gates are in a closed confor-
mation [10]. Thus, the free CP has latent enzymeactivity [11]. Opening of
theα ring requires the RP,which consists of two subcomplexes, the base
and the lid. The RP base contains six different ATPase subunits (Rpt1 to
Rpt6; RP triphosphatase) and four different non-ATPase subunits (Rpn1,
Rpn2, Rpn10 and Rpn13: RP non-triphosphatase). The six-membered











40 C. Enenkel / Biochimica et Biophysica Acta 1843 (2014) 39–46responsible for the ATP hydrolysis that promotes unfolding of the sub-
strate and its translocation into the CP cavity. Rpn10, a more distant
RP base subunit, recognizes the poly-ubiquitin chain that marks a pro-
tein for proteasomal degradation [3]. The lid contains at least nine
non-ATPase subunits. Rpn11, conferring an isopeptidase activity to the
RP lid, cleaves off the ubiquitin moieties from the poly-ubiquitin chain
of the target protein prior to its degradation [12,13].
Several proteasome-interacting proteins add to the plasticity of
proteasome conﬁgurations. A high molecular mass protein, named
Blm10 in yeast and PA200 in mammals, is the newest member of con-
served proteasomal activators [14–16]. The potential function of Blm10
in nuclear proteasome activation is reﬂected by the hypersensitivity of
blm10Δ mutants against DNA damaging agents [76]. Under normal
growth conditions Blm10-associated proteasomes constitute a minor
fraction of proteasome conﬁgurations. They predominate in proteasomal
mutants affecting CP maturation [14].
Despite compelling in vitro evidence that in the absence of RP, the CP
is able to degrade partly unfolded and unstructured non-ubiquitylated
proteins [17], it remains a subject of debate whether this also occurs
in vivo [18]. Signiﬁcant degradation of misfolded proteins by the CP
alone seems unlikely in living cells given the abundance of chaperones
and ubiquitin-conjugating machineries that guide potential protein












Fig. 1. In vivo localisation of GFP-labeled proteasomes during cell proliferation and quies-
cence. (A) Wild type yeast cells expressing GFP-labeled CP (via the reporter subunit β5)
and cherry red (RFP)-labeled histone H2Aweremonitored by direct ﬂuorescencemicrosco-
py using Nomarski optics (DIC), RFP and GFP ﬁlter sets. Dividing yeast cells are shown in the
left panels, and quiescent yeast cells are shown in the right panels. Bar, 2 μm. (B)Micrograph
of a humanmelanoma cell (lineMel JuSo)whichwas transfectedwith a GFP-tagged version
of the CP subunitα3 (left panel). Live cell imaging of dendrites from a rat hippocampal neu-
ron which was transfected with a GFP-tagged version of the yeast RP subunit Rpt1 [69].
Panel B is the image of melanoma cell.3. Localization of the proteasome in diving cells
Although it is now clear that proteasomes are largely nuclear in di-
viding cells (Fig. 1, left panels) and have the ability to move between
the cyto- and nucleoplasm to carry out protein degradation at the
right place and at the right time, the issue of proteasome movement
in and out of the nucleus was initially controversial.
In the following paragraph I will review the history of proteasome
localization studies and will also address the experimental limitations
leading to different conclusions about proteasome localizations. Early
studies by Franke and colleagues, which were later conﬁrmed by
Micesz and colleagues, localized proteasomes primarily to the nuclei
of Xenopus laevis oocytes and cultured mammalian cells [5,20,21].
Subsequent studies that relied on different antibodies and ﬁxation
methods to examine mammalian cells revealed that the majority
of proteasomal subunits were present in the cytoplasm [22]. Exami-
nation of cells from high cell density cultures revealed less pro-
nounced nuclear staining and increased cytoplasmic staining. These
observations shifted research to focus predominantly on cytoplasmic
protein breakdown [23] and led to the notion that efﬁcient degrada-
tion of nuclear substrates, such as the tumor suppressor p53 and
cyclin-dependent kinase inhibitors, required their export to the cyto-
plasm [24,25]. Other studies, however, showed that proteasomes
change their intracellular localization in cultured mammalian cells
depending on the cell cycle stage [23]. Proteasomes were observed
to accumulate at the nuclear periphery during mitosis and to be
predominantly nuclear in daughter cells after cytokinesis. During
interphase, proteasomes were seen in clusters in the cytoplasm and
at the nuclear matrix [26].
Recent studies on the localization of proteasomes have been great-
ly facilitated by the use of live cell imaging techniques that monitor
the movement of proteasomal subunits tagged with ﬂuorescent la-
bels, such as green ﬂuorescent protein (GFP). Several criteria must
be fulﬁlled to ensure that a tagged proteasomal subunit is suited as
a reporter of the respective proteasomal complex. First, the tagged
protein must be fully incorporated into the proteasomal complex
and second, it must not interfere with proteasome function [27]. If
the GFP tag interferes with the function of the fusion protein, maver-
ick labeled proteasomal subunits will behave like misfolded proteins.
Hence localization studies may reveal where maverick subunits aredegraded by proteasomal proteolysis and accidentally coincide with
the localization of the degrading enzyme.
Both in yeast and mammalian cells, proteasomal subunits can be
expressed as functional GFP fusion proteins. The ﬁrst example of a func-
tional GFP-labeled proteasomal subunit in mammals was the cytokine-
inducible iβ1 (Lmp2) that reports on the intracellularmovements of the
immune-speciﬁc CP in human ﬁbrosarcoma cells. GFP-labeled iβ1 was
found to be equally distributed throughout the nucleo- and cytoplasm
[28]. Fluorescence recovery after photobleaching experiments revealed
that the transport of GFP-labeled CP across the nuclear envelope oc-
curred slowly from the cyto- to the nucleoplasm. During mitosis,
when the nuclear envelope disintegrates, the CP diffuses throughout
thedividing cell. Immediately after cell division, the restored nuclear en-
velope once again forms a barrier for the diffusing CP [28]. Thus, it was
proposed that the presence of the immuno-CP in the nucleus depends
41C. Enenkel / Biochimica et Biophysica Acta 1843 (2014) 39–46on the mitotic breakdown of the nuclear envelope and that the
immuno-CP is hardly imported into the nucleus after the assembly of
the nuclear envelope. The standard CP is largely nuclear during cell pro-
liferation according to live imaging studies of human melanoma cells
that express a GFP-labeled version of the α3 subunit [27].
In yeast, homologous recombination techniques readily allow an es-
sential gene to be converted to a gene encoding a GFP-tagged version of
the gene product. Almost all proteasomal genes can be modiﬁed with a
GFP tag without interfering with cell proliferation. Thus, the GFP-
labeled subunits can be considered as excellent proteasome reporters.
The ﬁrst in vivo localization studies of GFP-labeled proteasomes in
budding and ﬁssion yeasts showed that most proteasomes, either CP (la-
beled by α4 and β5) or RP (labeled by Rpt1, Rpt4 and Rpn11), were nu-
clear and decorated the nuclear membranes, which at the cytoplasmic
side merge with the endoplasmic reticulum [29–31]. At the same time,
these observations were surprising as it had been anticipated that
proteasomes would be predominantly localized in the cytoplasm. Mean-
while imaging studies ﬁrmly established that proteasomes are primarily
nuclear in logarithmically growing yeast cells, independently of which
proteasomal subunit was labeled with GFP [32]. As mentioned above,
live cell imaging studies further showed that proteasomes are also pri-
marily nuclear in rapidly proliferating mammalian cells [33]. Although
most proteasomal substrates, such as short-lived proteins regulating
gene expression and cell cycle progression, seem to have nuclear func-
tions [34], it is possible that the nucleus contributes to the proteasome-
mediated degradation ofmisfolded proteins. Nuclear-speciﬁc chaperones
and ubiquitin-conjugatingmachineries have been identiﬁed and provide
quality control of damaged proteins in the nucleus [35]. Nuclear degrada-
tion of defective translation products can account for the observation that
misfolded cytosolic proteins are transported from the cytoplasm into the
nucleus prior to their degradation [36]. Theseﬁndings agreewith our pre-
vious studies that showed that the nuclear periphery is the major site of
proteasome-mediated proteolysis as assessed by examination of yeast
cells that had been soaked with proteasome-speciﬁc chromogenic sub-
strates [30]. In cultured mammalian cells components of the ubiquitin-
proteasome system also accumulate in nuclear speckles, Cajal bodies,
and PML bodies. Consistent with these observations, studies that
followed the fate of chromogenic substrates that were microinjected
into the nuclei of mammalian cells suggested that proteasome-
dependent degradation occurs in transient foci in the nucleoplasm [34].
Here, it is also worth to mention the advantage of GFP labeling
techniques as they allow simultaneous determination of the diversity
of proteasome complexes by native PAGE and of their in vivo localiza-
tion by live cell imaging techniques. Native PAGE followed by imaging
of the GFP moieties within a proteasomal subcomplex has led to the
identiﬁcation of more than ten different proteasome species indepen-
dent of their proteolytic activity (Fig. 2). [37].
4. Nuclear import of proteasomes in dividing cells
The question arises as to how proteasomes enter the nucleus of
yeast, a eukaryotic organism with a closed mitosis. Classical nuclear lo-
calization signals (NLSs) are present in several CP α subunits, but not
in β subunits [38]. NLSs are also present in the RP base subunits, Rpt2
and Rpn2 [39]. The proteasomal NLSs, when fused to non-nuclear
ﬂuorescent proteins, direct these reporter proteins into the nucleus
of digitonin-permeabilized mammalian cells and living yeast
cells [39–41]. However, analysis of the transport of pre-assembled
proteasomes into the nuclei of digitonin-permeabilized mammalian
cells indicated that their import is very inefﬁcient and independent of
the classical NLS pathway [42,43]. Our subsequent observations from
reconstitution assays supported these previous ﬁndings that mature
proteasomes are hardly transported through nuclear pores by the classi-
cal NLS receptor pathway [44,45]. In the classical NLS receptor pathway,
which is highly conserved from yeast to human, the NLS cargo is
recognized by the heterodimeric receptor, importin/karyopherin αβ.Karyopherinα binds the NLS cargo, while karyopherin βmediates an in-
teraction with the phenylalanine-glycine rich nuclear pore proteins that
are present along the passage through the nuclear pore. On the nucleo-
plasmic side of the nuclear pore, the transport complex encounters the
small GTPase, Ran. Ran in its GTP-bound form displaces the NLS cargo
and karyopherin α by binding to karyopherin β [46]. Intriguingly, not
only is the mature CP nuclear, but its inactive precursor complexes are
also primarily nuclear, suggesting that the nuclear CP is matured at its
destination (Fig. 3) [45].
Inactive precursor complexes of the CP are referred to as half-CP.
These complexes contain one α ring, the CP-dedicated chaperone,
Ump1, and β subunits with propeptides. Ump1 guides the dimerization
of two half-CPs into the pre-holo-CP [47]. Within the pre-holo-CP, the β
propeptides are cleaved off by autocatalysis and Ump1 is degraded by
the nascent CP [48]. An Ump1-GFP fusion protein, which fails to be rap-
idly degraded, mainly localizes to the nucleus of yeast [45]. Besides
Ump1, several chaperones contribute to the assembly of the CP, but
Ump1 controls the hierarchy of CP-dedicated chaperones [49]. If
CP-dedicated chaperones are absent, maturation of the CP is delayed
and pre-holo-CPs accumulate in the nucleus [14,49]. This observation
supports the conclusion that maturation of nuclear proteasomes occurs
in the nucleus. Also Pomp1, the human ortholog of Ump1, is present in
the nucleus [50]. Precursor complexes of immuno-CP accumulate in the
nucleus of neuronal cells, suggesting that maturation of immuno-CP is
attenuated in these nuclei [51].
Blm10, a 240 kDaHEAT-like repeat protein, associates with both the
half-CP and the pre-holo-CP [47,52,53]. Since Blm10 preferentially
binds to CPs with disordered axial channels in the α rings [54], we pro-
posed that Blm10 monitors assembly of α rings and acts to control CP
maturation until α ring gates are properly closed [14]. Consistent with
the localization of Ump1-associated precursor complexes, Blm10 is
also primarily nuclear in logarithmically growing yeast cells [53].
In the yeast srp1–49 mutant (E145K), which is defective in
karyopherin α, proteasomal subunits, including Ump1, are localized
to the cytoplasm [39,45,55]. The question arises as to why precursor
complexes instead of mature CP are the preferred import cargoes of
the classical NLS receptor karyopherin α.
In 1990, Keiji Tanaka proposed a model for nuclear import of the CP.
He hypothesized that two CP conformations exist, one import-
competent in which the NLSs are exposed, and one import-
incompetent in which the NLSs are masked [38]. In precursor com-
plexes, the NLSs are apparently exposed and facilitate nuclear import
of the precursor complexes by the classical NLS-dependent pathway
[45]. The β subunits, which lack NLSs, are piggybacked with the α ring
into the nucleus. In the mature CP, the α ring is closed and the NLSs
seem to be less accessible, which hinders nuclear import of the mature
CP. Structural studies of nuclear pore complexes indicate that the
phenylalanine-glycine rich proteins that line the nuclear pore are partly
unstructured [46]. Considering the possibility that the mature CP de-
grades non-ubiquitinated, unstructured, and misfolded proteins, it is
worth pointing out that collateral damage to the nuclear pore is un-
avoidable if themature CP enters the nuclear pore and interactswith na-
tively disordered phenylalanine-glycine rich nuclear pore proteins.
In budding yeast, the CP precursor complexes, the RP lid, and the
RP base seem to be imported separately into the nucleus by the
NLS-dependent pathway [39,56]. Rpt2 and Rpn2 confer NLSs to the
RP base [39]. Since the RP base is assembled mainly from two precur-
sor complexes, one containing Rpt2 and the other one containing
Rpn2, it is possible that assembly of the RP base occurs in the nucleus.
The import of separate Rpt2- and Rpn2-containing precursor com-
plexes is also consistent with reports that the RP base assembles on
a CP platform [57]. NLSs have not been identiﬁed for the RP lid sub-
units. Accessory NLS-containing, short-lived proteins, such as Sts1,
may confer NLS properties to some proteasomal subunits and facili-
tate their nuclear import by karyopherin αβ. Genetic analyses and
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43C. Enenkel / Biochimica et Biophysica Acta 1843 (2014) 39–46an interaction between Rpn11 and karyopherin α to facilitate nuclear
import of PR lid components [58]. Notably, deletion of the NLS of Sts1
affects not only the nuclear localization of the RP lid, but also nuclear
localization of the RP base and the CP, suggesting that Sts1 has a gen-
eral impact on nuclear localization of proteasomes [55]. The ﬁnding
that Sts1 is a crucial component in nuclear import of proteasomes is
consistent with previous studies showing that Cut8, the ﬁssion yeast
homolog of Sts1, anchors proteasomes to the nucleoplasmic side of
the nuclear membrane [59]. However, no mammalian counterpart
of Sts1/Cut8 has been identiﬁed yet [59,60].
It is reasonable to assume that multiple pathways including sever-
al karyopherins co-exist to trafﬁc CP and RP into the nucleus. For in-
stance Rpn11 not only interacts with Srp1, the essential karyopherin
α, but also interacts with non-essential β karyopherins, Kap104 and
Kap123 [61], suggesting that several karyopherins orchestrate nucle-
ar import of proteasomes. Also Nob1, a nuclear protein, was reported
to coordinate CP maturation and RP-CP assembly in the nucleus [62].
However, this function of Nob1 was challenged by later studies
reporting that Nob1 is involved in ribosome biogenesis [63].
The mechanism coordinating nuclear transport and assembly of
proteasomal subcomplexes into the holocomplex is not yet under-
stood. In yeast, the promoter of proteasomal genes contains common
proteasome-associated control elements (PACE) that are recognized
by the transcription factor Rpn4, the putative counterpart of mamma-
lian Nrf1 [64,65]. Rpn4 augments proteasomal gene transcription and
facilitates the expression of proteasomal subunits in stoichiometric
amounts. The assembled proteasome degrades Rpn4, its own tran-
scription factor, thus regulating proteasome homeostasis by a nega-
tive feedback circuit [66].
The orchestrated proteasomal gene expression and nuclear import
of proteasomal subcomplexes ascertain that proteasomal subcomplexes
arrive in the nucleus with similar stoichiometry and kinetics. It seems
conceivable that essential cargoes like proteasomal subcomplexes are
mainly imported by the essential nuclear import receptor karyopherin
αβ. Apparently, this lays the foundation that the holocomplex is assem-
bled in the nucleus as necessary.
5. Proteasome localizations in non-dividing cells
Most of the cells of our body, especially neuronal cells, do not divide
and instead arrest in the G0 stage of the cell cycle. Yeast cells that are
grown to stationary phase enter a G0-like stage referred to as quies-
cence. During the transition of yeast cells from logarithmic growth to
stationary phase, proteasomes migrate from the nuclear matrix to the
nuclear envelope. Although the signiﬁcance of proteasome movement
is not yet clear, it could reﬂect changes in proteolytic demands. In quies-
cent cells, proteasomes accumulate in one or two dot-like clusters on
the cytoplasmic side of the nuclear envelope (Fig. 1, right panels). This
phenomenon was studied in detail by Sagot and co-workers [67] who
coined the term proteasome storage granuli (PSG) for these dot-like
clusters. PSG are not surrounded by membranes and move freely
through the cytoplasm. They appear to pinch off the nuclear envelope,
when proteasomes are exported from the nucleus into the cytoplasm
upon the transition from proliferation to quiescence. During prolonged
quiescence, proteasomes are retained in the PSG and the nucleus re-
mains deﬁcient in proteasomes [67]. The question arises as to what is
the “molecular glue” that holds proteasomes together within the PSG.
Upon exit of cells from quiescence, this “molecular glue” resolves, PSG
rapidly clear and proteasomes relocate to the nucleus within a few mi-
nutes. Thus, PSG were assumed to serve as storage depot during quies-
cence [67]. Studies of the collection of yeast null mutants andFig. 2. Multiplicity of proteasome complexes in growing yeast cells as revealed by GFP-labe
lyzed by GFP imaging as described [37]. Proteasome complexes and Svedberg sedimentatio
species accumulate in the ump1Δmutants with defective CP maturation (lane 2). Structures
copy studies [75] with the license of Cell Press Elsevier.temperature-sensitive mutants expressing GFP-labeled proteasomes
may shed light into the process of PSG formation and clearance and elu-
cidate the factors that are required for their mobility and reversibility.
Motile dot-like proteasome clusters are also observed at the nuclear
periphery upon chemical inhibition of the proteasome in mammalian
cells or in temperature-sensitive proteasomal yeast mutants grown at
restrictive temperature. Like proteasome inhibitors, these proteasomal
mutations affect the protein degradation of cell cycle regulators and
cause cell cycle arrest. Although a genetically or chemically induced
cell cycle arrest is not equivalent to quiescence, inhibited proteasomes
appear to be sequestered into so-called juxta nuclear quality control
compartments (JUNQs) that are located at the cytoplasmic side of the
nuclear envelope. Since poly-ubiquitylated misfolded proteins were
detected in JUNQ, JUNQ was proposed to represent a major site of
proteasomal proteolysis. JUNQs clear, as soon as the mutants resume
growth at permissive temperature or the proteasome inhibitor is re-
moved [68]. It awaits future investigation whether PSG and JUNQs de-
scribe the same structures. If so, the underlying mechanism of their
formation and clearance seems to be conserved from yeast to men [68].
In mammalian cells, aggregation-prone proteins, such as poly-
glutamine-extended proteins, also accumulate in intranuclear protein
speckles. Photobleaching experiments usingGFP-labeled iβ1 (Lmp2) re-
vealed that proteasomes diffuse in and out of these intranuclear protein
speckles [27].
Although G0-arrested mammalian cells are difﬁcult to handle in cell
culture, pioneering work by Bingol and Schuman showed that neuronal
cells from rat hippocampal regions can be transfected with DNA
encoding GFP-labeled yeast Rpt1 [69]. Their studies revealed that in
these cells the yeast Rpt1, an RP base subunit, replaces its mammalian
counterpart. Thus, GFP-labeled Rpt1 is considered to be an excellent re-
porter of mammalian proteasomes in living neuronal cells. Intriguingly,
GFP-labeledmammalian proteasomes are clustered in cytosolic dot-like
structures in neuronal cells [69]. Local needs of coordinated protein deg-
radation for synaptic plasticity seem to recruit proteasomes from the
dendritic shaft into dot-like structures of the spines. The proteasome
movements were induced by N-methyl-D-aspartate (NMDA) treatment
and can be paralleled with NMDA-induced RP-CP dissociation as ob-
served by later biochemical studies [70].
Whether these proteasome clusters in neuronal cells have similar
functions like PSG or JUNQ in yeast needs to be investigated. A major
difference between these proteasome clusters and PSG/JUNQ is that
they are associated with the actin-based cytoskeleton of dendritic
spines and that they arise far away from the nucleus [69].
The abundant CAMKII kinase functions as a scaffold for the recruit-
ment of proteasomes into clusters in neuronal cells, but the molecular
link between the calcium-dependent proteasome clustering and the
CAMKII kinase-mediated phosphorylation of the proteasome is still
lacking [71]. One could imagine that rapidly interconverted protein
modiﬁcations like phosphorylation/dephosphorylation contribute to
proteasome self-assembly into clusters.
RecentlyN-myristoylation of Rpt2, an RP baseATPase,was reported to
regulate proteasome localization. Proteasomes without N-myristoylation
seem to leak out off the nucleus and to be sequestered into dot-like struc-
tures in the cytoplasm [72].
Far less understood is the physiological role of proteasome clusters.
Do they serve as a major site for proteasomal degradation of poly-
ubiquitylated proteins? The fact that RP-CP assemblies dissociate dur-
ing stationary phase in yeast [73] argues against this possibility in
quiescence, because intact RP-CP assemblies are required to degrade
poly-ubiquitylated proteins. Moreover, it is possible that RPs and CPs
are independently sequestered into PSG, providing even more supportled CP. Lysates were subjected to native polyacrylamide gels electrophoresis and ana-
n coefﬁcients were assigned. Compared with wild-type cells (lane 1) Blm10-associated




Fig. 3.Model of nuclear import of CP in dividing cells. In the cytoplasm of dividing yeast cells CP precursor complexes are assembled from newly synthesized subunits and Ump1, a
CP-dedicated chaperone. The NLSs within the α subunits of the CP precursor complexes are accessible for the classical NLS receptor karyopherin/importin αβ which mediates nu-
clear import of CP precursor complexes. In the nucleus, the CP is matured, Ump1 is degraded and the NLSs are masked by α ring closure and RP association.
44 C. Enenkel / Biochimica et Biophysica Acta 1843 (2014) 39–46for the assumption that poly-ubiquitylated proteins are not degraded
within proteasome clusters during quiescence.
6. Nuclear import of proteasomes upon exit from quiescence
As mentioned above, the PSG and JUNQ clear within a few minutes
after the addition of fresh nutrients to yeast cells and proteasomes
reappear in the nucleus again [67]. Upon exit from quiescence, the syn-
thesis of new proteasomal subunits needs to be derepressed before pre-
cursor complexes are available as possible import cargoes for the
classical NLS receptors. Thus, alternative mechanisms, most likely inde-
pendent of the classical NLS receptor karyopherinαβ, must exist for nu-
clear import of mature CP. The proteins mediating nuclear import of CP
and RP upon exit from quiescence are unknown in yeast.
Studies with a Xenopus reconstituted cell-free system showed that
pre-assembled CP is imported into the nucleus independent of the clas-
sical NLS receptor. The import-competent conformation of the mature
CP, which was isolated from unfertilized amphibian eggs, was found to
be associated with Rpn1, Rpn2, Hsp90 and karyopherin β but no
karyopherin α [44]. However, an Rpn2-dependent import mechanism
for the mature CP could not be identiﬁed in yeast (unpublished results).
This suggests that the mechanisms for nuclear import in Xenopus eggs
and quiescent yeast cells differ. Nonetheless, both cell systems have in
common that a rapid nuclear import of pre-assembled CPs is required
upon the resumption of cell division.
Finally I want to project the studies in quiescent yeast cells to
G0-arrested mammalian cells in which proteasomes also accumulate
in reversible and motile clusters [69]. I anticipate that proteasome
clusters will protect against neurodegenerative disorders, as long
as these clusters remain mobile and reversible. Co-localizations of
proteasomes with ubiquitin-positive protein inclusions are often
considered as hallmarks of many diseases like Parkinson's,
Alzheimer's and Huntington's [8]. In such cases, the burden ofubiquitylated proteins probably exceeds the degradation capacity
of the proteasome. This is similar to the situation provoked in cul-
tured cells that are exposed to proteasome inhibitors or that over-
express proteasomal substrates. The intriguing question is what fac-
tors transform soluble proteasome clusters into cytotoxic protein
aggregates, so-called aggresomes [74]. Post-translational modiﬁca-
tions related with aging may be the reason for the irreversibility
and immobility of protein clusters. These irreversible and immobile
protein clusters may ﬁnally lead to disease and death of quiescent
cells, unless autophagic processes are activated to remove them.
However, proteasome elimination by autophagy occurs at the ex-
pense of the cells' capability to rapidly reprogram nuclear protein
degradation by proteasomes in response to changing environmental
conditions.
Until today G0-arrested neuronal cells are still hardly feasible in cell
culture. Because of this, quiescent yeast cells may serve as the best eu-
karyotic model organism to understand the underlying mechanism of
the formation and clearance of proteasome clusters. Moreover, high
throughput screens are feasible in yeast to search for drugs that main-
tain the reversibility and motility of proteasome assemblies.
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